Risk Factors for Colorectal Cancer in Patients With Inflammatory Bowel Disease Undergoing Surveillance: a Prospective Cohort Study

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2011 by UMC Utrecht
Sponsor:
Collaborators:
Merck Sharp & Dohme Corp.
Ferring Pharmaceuticals
Information provided by (Responsible Party):
B. Oldenburg, UMC Utrecht
ClinicalTrials.gov Identifier:
NCT01464151
First received: October 31, 2011
Last updated: NA
Last verified: October 2011
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2018
  Estimated Primary Completion Date: July 2018 (Final data collection date for primary outcome measure)